These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

330 related items for PubMed ID: 22718483

  • 21. Efficacy and safety of splenectomy in immune thrombocytopenic purpura: long-term results of 402 cases.
    Vianelli N, Galli M, de Vivo A, Intermesoli T, Giannini B, Mazzucconi MG, Barbui T, Tura S, Baccaranion M, Gruppo Italiano per lo Studio delle Malattie Ematologiche dell'Adulto.
    Haematologica; 2005 Jan; 90(1):72-7. PubMed ID: 15642672
    [Abstract] [Full Text] [Related]

  • 22. A multi-centre retrospective study of rituximab use in the treatment of relapsed or resistant warm autoimmune haemolytic anaemia.
    Maung SW, Leahy M, O'Leary HM, Khan I, Cahill MR, Gilligan O, Murphy P, McPherson S, Jackson F, Ryan M, Hennessy B, McHugh J, Goodyer M, Bacon L, O'Gorman P, Nee A, O'Dwyer M, Enright H, Saunders J, O'Keeffe D.
    Br J Haematol; 2013 Oct; 163(1):118-22. PubMed ID: 23909468
    [Abstract] [Full Text] [Related]

  • 23. Rituximab for the treatment of refractory idiopathic thrombocytopenic purpura (ITP) and thrombotic thrombocytopenic purpura (TTP): report of three cases.
    Koulova L, Alexandrescu D, Dutcher JP, O'Boyle KP, Eapen S, Wiernik PH.
    Am J Hematol; 2005 Jan; 78(1):49-54. PubMed ID: 15609292
    [Abstract] [Full Text] [Related]

  • 24. Long-term follow-up of children with refractory immune thrombocytopenia treated with rituximab.
    Matsubara K, Takahashi Y, Hayakawa A, Tanaka F, Nakadate H, Sakai M, Maeda N, Oka T, Ishii E, Bessho F, Morimoto T, Goto H, Hashii Y, Hatakeyama N, Shirahata A, Imaizumi M.
    Int J Hematol; 2014 Apr; 99(4):429-36. PubMed ID: 24609717
    [Abstract] [Full Text] [Related]

  • 25. Overview of 321 patients with idiopathic thrombocytopenic purpura. Retrospective analysis of the clinical features and response to therapy.
    Pamuk GE, Pamuk ON, Başlar Z, Ongören S, Soysal T, Ferhanoğlu B, Aydin Y, Ulkü B, Aktuğlu G, Akman N.
    Ann Hematol; 2002 Aug; 81(8):436-40. PubMed ID: 12224000
    [Abstract] [Full Text] [Related]

  • 26. Therapy with rituximab for autoimmune pemphigus: results from a single-center observational study on 42 cases with long-term follow-up.
    Cianchini G, Lupi F, Masini C, Corona R, Puddu P, De Pità O.
    J Am Acad Dermatol; 2012 Oct; 67(4):617-22. PubMed ID: 22243765
    [Abstract] [Full Text] [Related]

  • 27. Long-term follow-up analysis after rituximab therapy in children with refractory symptomatic ITP: identification of factors predictive of a sustained response.
    Parodi E, Rivetti E, Amendola G, Bisogno G, Calabrese R, Farruggia P, Giordano P, Matarese SM, Nardi M, Nobili B, Notarangelo LD, Russo G, Vimercati C, Zecca M, De Mattia D, Ramenghi U.
    Br J Haematol; 2009 Feb; 144(4):552-8. PubMed ID: 19036077
    [Abstract] [Full Text] [Related]

  • 28. [Treatment outcome of immune thrombocytopenia].
    Iványi JL, Marton E, Plander M.
    Orv Hetil; 2012 Oct 14; 153(41):1613-21. PubMed ID: 23045311
    [Abstract] [Full Text] [Related]

  • 29. Durability and factors associated with long term response after splenectomy for primary immune thrombocytopenia (ITP) and outcome of relapsed or refractory patients.
    Aleem A.
    Platelets; 2011 Oct 14; 22(1):1-7. PubMed ID: 20964585
    [Abstract] [Full Text] [Related]

  • 30. [Rituximab treatment for adults with steroid-resistant idiopathic thrombocytopenic purpura].
    Wang W, Yu QH, Zhang HY, Chu XX, Chen F, Zhang CQ, Zhou YH, Hou M.
    Zhonghua Nei Ke Za Zhi; 2008 Mar 14; 47(3):225-7. PubMed ID: 18785508
    [Abstract] [Full Text] [Related]

  • 31. Effect of a single-cycle alternative dosing regimen for rituximab for recalcitrant pemphigus: a case series of 9 patients.
    Matsukura S, Knowles SR, Walsh S, Shear NH.
    Arch Dermatol; 2012 Jun 14; 148(6):734-9. PubMed ID: 22351790
    [Abstract] [Full Text] [Related]

  • 32. Very long-term remission induced by short-term rituximab monotherapy in a patient with heavily pretreated, chronic immune thrombocytopenic purpura.
    Clausen MR, Segel E, Brandsborg M, d'Amore F.
    Eur J Haematol; 2011 Mar 14; 86(3):256-9. PubMed ID: 21166717
    [Abstract] [Full Text] [Related]

  • 33. Rituximab monotherapy with eight weekly infusions for relapsed or refractory patients with indolent B cell non-Hodgkin lymphoma mostly pretreated with rituximab: a multicenter phase II study.
    Tobinai K, Igarashi T, Itoh K, Kurosawa M, Nagai H, Hiraoka A, Kinoshita T, Uike N, Ogura M, Nawano S, Mori S, Ohashi Y, IDEC-C2B8 Study Group.
    Cancer Sci; 2011 Sep 14; 102(9):1698-705. PubMed ID: 21645173
    [Abstract] [Full Text] [Related]

  • 34. The choice of second-line therapy in steroid-resistant immune thrombocytopenia: role of platelet kinetics in a single-centre long-term study.
    Palandri F, Polverelli N, Catani L, Sollazzo D, Romano M, Levorato M, Vianelli N.
    Am J Hematol; 2014 Nov 14; 89(11):1047-50. PubMed ID: 25103500
    [Abstract] [Full Text] [Related]

  • 35. Efficacy and safety of splenectomy in adult chronic immune thrombocytopenia.
    Zoghlami-Rintelen C, Weltermann A, Bittermann C, Kyrle PA, Pabinger I, Lechner K, Wenzl E.
    Ann Hematol; 2003 May 14; 82(5):290-4. PubMed ID: 12739064
    [Abstract] [Full Text] [Related]

  • 36. Rituximab before splenectomy in adults with primary idiopathic thrombocytopenic purpura: a meta-analysis.
    Auger S, Duny Y, Rossi JF, Quittet P.
    Br J Haematol; 2012 Aug 14; 158(3):386-98. PubMed ID: 22612239
    [Abstract] [Full Text] [Related]

  • 37. Long-term observation of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis treated with rituximab.
    Stasi R, Stipa E, Del Poeta G, Amadori S, Newland AC, Provan D.
    Rheumatology (Oxford); 2006 Nov 14; 45(11):1432-6. PubMed ID: 16632482
    [Abstract] [Full Text] [Related]

  • 38. Rituximab for remission maintenance in relapsing antineutrophil cytoplasmic antibody-associated vasculitis.
    Smith RM, Jones RB, Guerry MJ, Laurino S, Catapano F, Chaudhry A, Smith KG, Jayne DR.
    Arthritis Rheum; 2012 Nov 14; 64(11):3760-9. PubMed ID: 22729997
    [Abstract] [Full Text] [Related]

  • 39. Long term follow-up after splenectomy performed for immune thrombocytopenic purpura (ITP).
    Schwartz J, Leber MD, Gillis S, Giunta A, Eldor A, Bussel JB.
    Am J Hematol; 2003 Feb 14; 72(2):94-8. PubMed ID: 12555211
    [Abstract] [Full Text] [Related]

  • 40. Twenty years experience with treatment of idiopathic thrombocytopenic purpura in a single department: results in 490 cases.
    Schiavotto C, Rodeghiero F.
    Haematologica; 1993 Feb 14; 78(6 Suppl 2):22-8. PubMed ID: 8039754
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.